» Articles » PMID: 24400072

Gene Expression Profiles of Human Adipose Tissue-derived Mesenchymal Stem Cells Are Modified by Cell Culture Density

Overview
Journal PLoS One
Date 2014 Jan 9
PMID 24400072
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies conducted cell expansion ex vivo using low initial plating densities for optimal expansion and subsequent differentiation of mesenchymal stem cells (MSCs). However, MSC populations are heterogeneous and culture conditions can affect the characteristics of MSCs. In this study, differences in gene expression profiles of adipose tissue (AT)-derived MSCs were examined after harvesting cells cultured at different densities. AT-MSCs from three different donors were plated at a density of 200 or 5,000 cells/cm(2). After 7 days in culture, detailed gene expression profiles were investigated using a DNA chip microarray, and subsequently validated using a reverse transcription polymerase chain reaction (RT-PCR) analysis. Gene expression profiles were influenced primarily by the level of cell confluence at harvest. In MSCs harvested at ∼90% confluence, 177 genes were up-regulated and 102 genes down-regulated relative to cells harvested at ∼50% confluence (P<0.05, FC>2). Proliferation-related genes were highly expressed in MSCs harvested at low density, while genes that were highly expressed in MSCs harvested at high density (∼90% confluent) were linked to immunity and defense, cell communication, signal transduction and cell motility. Several cytokine, chemokine and growth factor genes involved in immunosuppression, migration, and reconstitution of damaged tissues were up-regulated in MSCs harvested at high density compared with MSCs harvested at low density. These results imply that cell density at harvest is a critical factor for modulating the specific gene-expression patterns of heterogeneous MSCs.

Citing Articles

Activation of central and peripheral transient receptor potential melastatin 8 increases susceptibility to spreading depolarization and facilitates trigeminal neuroinflammation.

Liu T, Chen P, Tseng C, Chen Y, Chen J, Ni T J Headache Pain. 2025; 26(1):55.

PMID: 40087597 DOI: 10.1186/s10194-025-01997-2.


The Effect of Bone Marrow Mesenchymal Stem Cells on Nestin and Gene Expression and Spatial Learning (Percent Alternation Y-Maze Test) against AlCl-Induced Alzheimer's-like Pathology in a Rat Model.

Annita , Revilla G, Ali H, Almurdi Iran J Med Sci. 2024; 49(7):441-449.

PMID: 39114632 PMC: 11300943. DOI: 10.30476/ijms.2023.98912.3104.


The Decellularized Cell-Derived Extracellular Matrix Enhances the Paracrine Function of Human Mesenchymal Stromal/Stem Cells.

Ushakov R, Ratushnyy A, Buravkova L, Tolkunova E, Burova E Int J Mol Sci. 2024; 25(4).

PMID: 38397096 PMC: 10889327. DOI: 10.3390/ijms25042419.


Comparative transcriptome analysis of bone marrow resident versus culture-expanded mouse mesenchymal stem/stromal cells.

Haga C, Booker C, Strivelli J, Boregowda S, Phinney D Cytotherapy. 2024; 26(5):498-505.

PMID: 38372680 PMC: 11065607. DOI: 10.1016/j.jcyt.2024.01.008.


Scalable Generation of Pre-Vascularized and Functional Human Beige Adipose Organoids.

Escudero M, Vaysse L, Eke G, Peyrou M, Villarroya F, Bonnel S Adv Sci (Weinh). 2023; 10(31):e2301499.

PMID: 37731092 PMC: 10625054. DOI: 10.1002/advs.202301499.


References
1.
Battiwalla M, Hematti P . Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy. 2009; 11(5):503-15. PMC: 2766085. DOI: 10.1080/14653240903193806. View

2.
COLTER D, Class R, DiGirolamo C, Prockop D . Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci U S A. 2000; 97(7):3213-8. PMC: 16218. DOI: 10.1073/pnas.97.7.3213. View

3.
da Silva Meirelles L, Maria Fontes A, Covas D, Caplan A . Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 2009; 20(5-6):419-27. DOI: 10.1016/j.cytogfr.2009.10.002. View

4.
Abarbanell A, Coffey A, Fehrenbacher J, Beckman D, Herrmann J, Weil B . Proinflammatory cytokine effects on mesenchymal stem cell therapy for the ischemic heart. Ann Thorac Surg. 2009; 88(3):1036-43. DOI: 10.1016/j.athoracsur.2009.02.093. View

5.
Barbash I, Chouraqui P, Baron J, Feinberg M, Etzion S, Tessone A . Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation. 2003; 108(7):863-8. DOI: 10.1161/01.CIR.0000084828.50310.6A. View